Isoket Retard (Isosorbide Dinitrate)

• Isoket Retard belongs to the organic nitrate class and is used in cardiovascular conditions where vasodilation is required.
• Angina pectoris: reduces the frequency and severity of chest pain episodes.
• Chronic heart failure: improves exercise tolerance and lowers symptoms of fluid overload.
• Prophylaxis of angina attacks: helps prevent angina episodes during physical exertion or stress.

• Isosorbide dinitrate is metabolized to release nitric oxide, which activates guanylate cyclase in vascular smooth muscle. The resulting increase in cyclic GMP causes relaxation of arterial and venous smooth muscle, producing vasodilation, reduced preload and afterload, and consequently lower myocardial oxygen demand.

Isoket Retard may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects

• Headache: throbbing or pressure‑type pain.
• Flushing: warmth and redness of the face or neck.
• Dizziness or light‑headedness, especially on standing.
• Hypotension: low blood pressure causing faintness.
• Nausea or upset stomach.
• Palpitations: awareness of rapid or irregular heartbeat.

Serious or Rare Side Effects

• Severe hypotension leading to syncope.
• Methemoglobinemia: reduced oxygen‑carrying capacity of blood.
• Allergic reactions: rash, itching, swelling, or difficulty breathing.
• Tachyphylaxis: rapid loss of drug effectiveness.
• Myocardial ischemia worsening due to excessive vasodilation.

• Before prescribing Isoket Retard, clinicians should consider several safety aspects.
• Avoid abrupt discontinuation: may precipitate rebound angina.
• Monitor blood pressure: risk of hypotension, especially in volume‑depleted patients.
• Assess for concurrent nitrate therapy: combined use can cause severe hypotension.
• Caution in patients with severe anemia or elevated intracranial pressure.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Isosorbide dinitrate interacts with several drug classes that influence vascular tone or nitric‑oxide pathways.

Major Interactions (Avoid)

• Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause profound hypotension.
• Other nitrates or nitroglycerin preparations: additive vasodilatory effect.
• Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers): can amplify blood‑pressure lowering.

Moderate Interactions (Monitor Closely)

• Diuretics: may increase risk of hypotension and electrolyte imbalance.
• Alcohol: can enhance vasodilatory effects and dizziness.
• Certain antibiotics (e.g., macrolides): may affect metabolism and plasma levels.